No Data
No Data
No Data
No Data
No Data
東瑞製葯:2023 年報
Futu NewsApr 19 06:44 ET · Announcements
DAWNRAYS PHARMA To Go Ex-Dividend On May 28th, 2024 With 0.065 HKD Dividend Per Share
March 25th - $DAWNRAYS PHARMA(02348.HK)$ is trading ex-dividend on May 28th, 2024. Shareholders of record on May 29th, 2024 will receive 0.065 HKD dividend per share on June 12th, 2024. The ex-div
moomoo NewsMar 25 05:05 ET
Dawnrays' 2023 Profit Falls 9% on Lower Revenue
Dawnrays Pharmaceutical's (HKG:2348) attribrtuable profit fell 9% to 326 million yuan, or 0.2174 yuan per share, in 2023, from 358.1 million yuan, or 0.2389 yuan per share, in 2022, according to a Friday filing with the Hong Kong bourse.
MT NewswiresMar 25 05:03 ET
Changes in Hong Kong stocks | Dongrui Manufacturing (02348) fell by more than 10%. Profit attributable to shareholders of $326 million in 2023 decreased by 8.95% year-on-year
Dongrui Manufacturing (02348) fell by more than 10%, down 12.88% at press time, to HK$1.15, with a turnover of HK$1.54 million.
Zhitong FinanceMar 24 22:26 ET
Dongrui Pharmaceuticals (02348) will pay a final dividend of HK6.5 cents per share on June 12
Dongrui Pharmaceuticals (02348) announced that it will pay a final dividend of HK6.5 cents per share on June 12, 2024.
Zhitong FinanceMar 24 06:16 ET
The annual profit attributable to owners of Dongrui Pharmaceuticals (02348.HK) was about 326 million yuan, a year-on-year decrease of about 9.0%
Gelonghui, March 22丨Dongrui Pharmaceutical (02348.HK) announced that for the year ended December 31, 2023, the company recorded revenue of about RMB 1.15 billion, a year-on-year decrease of about 9.9%. Profit attributable to owners of parent companies was approximately RMB 326 million, a year-on-year decrease of approximately 9.0%. The Board recommended a year-end dividend of HK$0.065 per share.
Gelonghui FinanceMar 22 11:03 ET
No Data
No Data